SIC
BMY icon

Salem Investment Counselors’s Bristol-Myers Squibb BMY Stock Holding History

Salem Investment Counselors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
21,310
+493
+2% +$28.3K 0.03% 212
2026
Q1 		$1.26M Sell
20,817
-351
-2% -$20.5K 0.04% 197
2025
Q4 		$1.14M Sell
21,168
-768
-4% -$36.9K 0.03% 196
2025
Q3 		$989K Sell
21,936
-508
-2% -$23.7K 0.03% 211
2025
Q2 		$1.04M Sell
22,444
-8,194
-27% -$402K 0.03% 199
2025
Q1 		$1.87M Sell
30,638
-570
-2% -$33.2K 0.07% 151
2024
Q4 		$1.77M Sell
31,208
-1,105
-3% -$61.7K 0.06% 162
2024
Q3 		$1.67M Sell
32,313
-3,201
-9% -$150K 0.05% 168
2024
Q2 		$1.47M Sell
35,514
-40,854
-53% -$1.83M 0.05% 171
2024
Q1 		$4.14M Sell
76,368
-6,245
-8% -$318K 0.14% 101
2023
Q4 		$4.24M Sell
82,613
-20,105
-20% -$1.06M 0.15% 92
2023
Q3 		$5.96M Sell
102,718
-2,229
-2% -$137K 0.23% 67
2023
Q2 		$6.71M Sell
104,947
-4,051
-4% -$272K 0.24% 65
2023
Q1 		$7.55M Buy
108,998
+10,714
+11% +$756K 0.3% 60
2022
Q4 		$7.07M Buy
98,284
+8,888
+10% +$670K 0.3% 62
2022
Q3 		$6.36M Sell
89,396
-4
-0% -$290 0.29% 57
2022
Q2 		$6.93M Buy
89,400
+4,188
+5% +$319K 0.32% 54
2022
Q1 		$6.22M Sell
85,212
-13,395
-14% -$899K 0.24% 66
2021
Q4 		$6.15M Buy
98,607
+2,903
+3% +$170K 0.21% 73
2021
Q3 		$5.66M Buy
95,704
+3,179
+3% +$209K 0.31% 72
2021
Q2 		$6.18M Buy
92,525
+28,736
+45% +$1.87M 0.34% 65
2021
Q1 		$4.03M Buy
63,789
+7,758
+14% +$483K 0.25% 84
2020
Q4 		$3.48M Buy
56,031
+91
+0.2% +$5.6K 0.23% 87
2020
Q3 		$3.37M Buy
55,940
+7,955
+17% +$479K 0.26% 79
2020
Q2 		$2.82M Buy
47,985
+4,110
+9% +$246K 0.24% 85
2020
Q1 		$2.45M Buy
43,875
+13,036
+42% +$797K 0.25% 83
2019
Q4 		$1.98M Sell
30,839
-868
-3% -$49.7K 0.16% 113
2019
Q3 		$1.61M Sell
31,707
-29,169
-48% -$1.37M 0.15% 120
2019
Q2 		$2.76M Sell
60,876
-25,671
-30% -$1.2M 0.25% 91
2019
Q1 		$5.37M Buy
86,547
+4,483
+5% +$223K 0.55% 46
2018
Q4 		$4.27M Sell
82,064
-4,483
-5% -$241K 0.54% 48
2018
Q3 		$5.37M Sell
86,547
-1,558
-2% -$92.5K 0.55% 46
2018
Q2 		$4.88M Sell
88,105
-13,704
-13% -$740K 0.45% 48
2018
Q1 		$6.28M Sell
101,809
-2,708
-3% -$174K 0.71% 39
2017
Q4 		$6.41M Buy
104,517
+2,007
+2% +$126K 0.69% 38
2017
Q3 		$6.63M Buy
102,510
+4,318
+4% +$252K 0.77% 37
2017
Q2 		$5.47M Sell
98,192
-1,793
-2% -$97.6K 0.63% 44
2017
Q1 		$5.45M Buy
99,985
+6,236
+7% +$342K 0.58% 48
2016
Q4 		$5.48M Buy
93,749
+369
+0.4% +$20.2K 0.63% 49
2016
Q3 		$50.4K Buy
93,380
+2,546
+3% +$164K 0.66% 46
2016
Q2 		$6.68M Sell
90,834
-223
-0.2% -$15.8K 0.8% 40
2016
Q1 		$5.82M Sell
91,057
-1,535
-2% -$96.8K 0.72% 42
2015
Q4 		$6.37M Sell
92,592
-415
-0.4% -$27.4K 0.81% 39
2015
Q3 		$5.46M Sell
93,007
-1,729
-2% -$110K 0.71% 39
2015
Q2 		$6.3M Buy
94,736
+1,520
+2% +$100K 0.77% 37
2015
Q1 		$6.01M Sell
93,216
-815
-0.9% -$51K 0.72% 41
2014
Q4 		$5.55M Buy
94,031
+1,550
+2% +$87.4K 0.66% 44
2014
Q3 		$4.73M Sell
92,481
-3,822
-4% -$191K 0.57% 51
2014
Q2 		$4.67M Sell
96,303
-170
-0.2% -$8.38K 0.57% 53
2014
Q1 		$5.01M Sell
96,473
-4,093
-4% -$218K 0.62% 51
2013
Q4 		$5.34M Sell
100,566
-3,182
-3% -$162K 0.7% 47
2013
Q3 		$4.8M Buy
103,748
+430
+0.4% +$18.9K 0.67% 52
2013
Q2 		$4.62M Buy
+103,318
New +$4.49M 0.67% 51

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Salem Investment Counselors's BMY Position: Q2 2026 in Review

Salem Investment Counselors increased its Bristol-Myers Squibb (BMY) stake by 2.4% in Q2 2026, buying an estimated $28.3K and bringing the position to 21,310 shares worth $1.23M. The position accounts for 0.03% of the portfolio, ranked #212.

Salem Investment Counselors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.55M in Q1 2023. 1,306 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Salem Investment Counselors held 21,310 shares of Bristol-Myers Squibb worth $1.23M as of Q2 2026.
  • Salem Investment Counselors bought 493 Bristol-Myers Squibb shares in Q2 2026, an estimated $28.3K.
  • Bristol-Myers Squibb made up 0.03% of Salem Investment Counselors's portfolio in Q2 2026, its #212 holding.
  • Salem Investment Counselors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Salem Investment Counselors's Bristol-Myers Squibb position peaked at $7.55M in Q1 2023.
  • 1,306 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.